Capital Performance Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,242
Closed -$2.47K 1273
2024
Q3
$2.47K Buy
+1,242
New +$2.47K ﹤0.01% 1467